Herbal Medicine Product Manufacturing, Veterinary

Nationally yes — but NOT in Bali. KBLI 21023 (Industri Produk Obat Bahan Alam untuk Hewan) is TERBUKA (100% foreign ownership) at the national level, but in Bali it is blocked for a PT PMA under the 13 May 2026 moratorium. OSS risk at scale Besar is Rendah/Menengah-Rendah on every scope → blocked by Bali moratorium 13 May 2026 Outside Bali it is open to a PT PMA with no local partner required. (Source: Perpres 10/2021 as amended by Perpres 49/2021 — the investment-list annexes predate KBLI 2025; per-code crosswalk audit in progress.)

KBLI 21023 has a Menengah Rendah risk classification. Required license: NIB + Sertifikat Standar. Processing time: Otomatis.

KBLI 21023 is the Indonesian business classification code for "Industri Produk Obat Bahan Alam untuk Hewan" (Herbal Medicine Product Manufacturing, Veterinary). It falls under Section C of KBLI 2025, the Indonesian Standard Industrial Classification updated by BPS (Regulation 7/2025). The June 2026 KBLI 2025 transition window has closed; operators should verify the code's current OSS/NIB treatment before relying on it for licensing, reporting, or amendments.

KBLI 21023 was mapped from previous code 21023 (KBLI 2020). This is a direct match — the code number and scope remained the same. The June 2026 KBLI 2025 transition window has closed. If an NIB still relies on legacy KBLI 2020 mappings, treat the migration as overdue and verify/remediate the OSS record before new license applications, amendments, LKPM, import approvals, or investor/worker sponsorship.